Mediware Renews Relationship w

The three deals that Mediware has completed since November 2007 have helped it broaden its product line and deepen its core business...Read More

Mediware Renews Relationship with

William Blair & Company

LENEXA, KS July 28, 2010 - Mediware Information Systems, Inc. (Nasdaq: MEDW) Mediware Information Systems, Inc. (NASDAQ: MEDW), a specialist provider of information systems focused on complex clinical solutions for Blood Management, Medication Management and Performance Management, today announced that it is renewing its relationship with its long standing financial advisor, William Blair & Company.

As part of the ongoing agreement, Mediware management will be working with William Blair to explore a variety of strategic alternatives to enhance shareholder value. The company routinely performs internal strategic assessments and has not set a definitive timetable for completion of the evaluation. There can be no assurance that the evaluation will lead to any change in operating plans for the company or result in the pursuit of any specific alternative.

As in the past, the company intends to disclose developments regarding this process only if and when material.

About Mediware
Mediware delivers interoperable best-of-breed software systems that integrate with electronic medical records to improve efficiencies and address safety concerns enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; and business intelligence-based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market. For more information about Mediware products and services, visit our web site at www.mediware.com.

###

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.